New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers search for solutions to 'invisible threat' that affects cancer care workers

Researchers search for solutions to 'invisible threat' that affects cancer care workers

by University of MichiganVisual abstracts describes the study's findings. Credit: University of Michigan School of NursingChemotherapy drugs are lifesaving to cancer patients, but these toxic
Oncology June 01,2024
Researchers search for solutions to 'invisible threat' that affects cancer care workers

Researchers search for solutions to 'invisible threat' that affects cancer care workers

by University of MichiganVisual abstracts describes the study's findings. Credit: University of Michigan School of NursingChemotherapy drugs are lifesaving to cancer patients, but these toxic
Oncology June 01,2024
Study provides insights into early breast cancer development in individuals with BRCA2 mutations

Study provides insights into early breast cancer development in individuals with BRCA2 mutations

by National University of SingaporeBrca2mut/WTmammary glands are morphologically similar to wild-type mammary glands in young and aged mice. Credit:Nature Communications(2023).
Oncology June 01,2024
Study provides insights into early breast cancer development in individuals with BRCA2 mutations

Study provides insights into early breast cancer development in individuals with BRCA2 mutations

by National University of SingaporeBrca2mut/WTmammary glands are morphologically similar to wild-type mammary glands in young and aged mice. Credit:Nature Communications(2023).
Oncology June 01,2024
Study hints at new target to improve immune therapy in triple-negative breast cancer

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi
Oncology June 01,2024
Study hints at new target to improve immune therapy in triple-negative breast cancer

Study hints at new target to improve immune therapy in triple-negative breast cancer

by CU Anschutz Medical CampusHeide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improvi
Oncology June 01,2024
Researchers find new way to target childhood cancer

Researchers find new way to target childhood cancer

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainAn Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the child
Oncology June 01,2024
Researchers find new way to target childhood cancer

Researchers find new way to target childhood cancer

by Children's Cancer Institute AustraliaCredit: CC0 Public DomainAn Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the child
Oncology June 01,2024
Researchers testing new brain cancer vaccine

Researchers testing new brain cancer vaccine

by Rush University Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Rush University Medical Center is part of a new clinical trial testing whether an experimental vacci
Oncology June 01,2024
Researchers testing new brain cancer vaccine

Researchers testing new brain cancer vaccine

by Rush University Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Rush University Medical Center is part of a new clinical trial testing whether an experimental vacci
Oncology June 01,2024
Researchers developing test for early breast lesions

Researchers developing test for early breast lesions

by Angela Koenig,University of Cincinnati Academic Health CenterWeber's research has made key contributions to understanding the molecular mechanisms of metastasis. Credit: University of Cin
Oncology June 01,2024
Researchers developing test for early breast lesions

Researchers developing test for early breast lesions

by Angela Koenig,University of Cincinnati Academic Health CenterWeber's research has made key contributions to understanding the molecular mechanisms of metastasis. Credit: University of Cin
Oncology June 01,2024
Study examines treatment options for women with recurrent ovarian cancer

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit
Oncology June 01,2024
Study examines treatment options for women with recurrent ovarian cancer

Study examines treatment options for women with recurrent ovarian cancer

by WileyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) and mucinous epit
Oncology June 01,2024
Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes
Oncology June 01,2024
Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes
Oncology June 01,2024
Researchers demonstrate RAS dimers are essential for cancer

Researchers demonstrate RAS dimers are essential for cancer

by Cathy Frisinger,UT Southwestern Medical CenterRAS oncogenes work in pairs, known as "dimers." Credit: UT SouthwesternMutated RAS genes are some of the most common genetic drivers of
Oncology June 01,2024
Researchers demonstrate RAS dimers are essential for cancer

Researchers demonstrate RAS dimers are essential for cancer

by Cathy Frisinger,UT Southwestern Medical CenterRAS oncogenes work in pairs, known as "dimers." Credit: UT SouthwesternMutated RAS genes are some of the most common genetic drivers of
Oncology June 01,2024
Researchers identify way to block alphavirus infection

Researchers identify way to block alphavirus infection

by Washington University in St. LouisCredit:Cell(2023). DOI: 10.1016/j.cell.2023.09.007Researchers at Washington University School of Medicine in St. Louis have found an innovative wa
Public Health & Prevention June 01,2024
Researchers identify way to block alphavirus infection

Researchers identify way to block alphavirus infection

by Washington University in St. LouisCredit:Cell(2023). DOI: 10.1016/j.cell.2023.09.007Researchers at Washington University School of Medicine in St. Louis have found an innovative wa
Public Health & Prevention June 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com